Paul S Giacomini

9PUBLICATIONS
31CO-AUTHORS
Vision scienceHaematological tumoursNeurology and neuromuscular diseasesToxicology (incl. clinical toxicology)Biomechanics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 10, 2026
Eye tracking as a digital biomarker in neurodegenerative diseases.

Paul S Giacomini, Patrice Voss, Virginia Devonshire

|Jan 12, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.

Koji Shinoda, Rui Li, Ayman Rezk

|Jul 29, 2022
Permanent tissue damage in multiple sclerosis lesions is associated with reduced pre-lesion myelin and axon volume fractions.

Ian J Tagge, Ilana R Leppert, Dumitru Fetco

|Mar 01, 2022
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years.

Stephen L Hauser, Anne H Cross, Kevin Winthrop

|Dec 14, 2019
Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting: PROTEC.

T Berger, B Brochet, L Brambilla

|Dec 16, 2016
Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis.

Rui Li, Ayman Rezk, Mathab Ghadiri

Pageof 2

Frequent Collaborators

2 joint publications

Anne H Cross

2 joint publications

Sarah A Morrow

1 joint publications

T Berger

1 joint publications

Mathab Ghadiri